ICICI Prudential Mutual Fund launches the Nifty Pharma ETF NFO on October 12, offering targeted exposure to India's growing ...
The project will be executed on a divisible turnkey basis and is scheduled for commissioning within 32 months from the ...
The shares traded at an average price of ₹89.53 apiece, taking the total transaction value to around ₹818 crore. The volume ...
Rishi Kohli, Chief Investment Officer at JioBlackRock Asset Management Company, believes largecap stocks offer better ...
Senco Gold reported around 31% revenue growth in Q2 and expects festive and wedding demand to support sales, while retaining ...
X-Analysts CEO Mukesh Sahdev says shipping costs four to five times above normal and disruptions to oil flows could keep ...
Airtel Money debuted on the London Stock Exchange in the bourse's largest IPO in five years, valuing the mobile payments ...
Sharif renewed Pakistan's support for Trump's Nobel bid, crediting him with helping secure the May 2025 ceasefire with India, ...
US and European telecom stocks tumbled following SpaceX's acquisition of an $8 dollar spectrum portfolio, raising ...
Complete Circle's Gurmeet Chadha says lower transaction and capital gains taxes, along with gradual regulatory changes, could ...
Kunal Dhamesha, Pharma & Healthcare Research Analyst at Macquarie Capital estimates a mid-teens EBITDA hit for Max Healthcare ...
Earlier today, BS Ajai Kumar, chairman of Healthcare Global Enterprises, told CNBC-TV18 that the economics of manufacturing and supplying certain cancer drugs could become a concern when margins are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results